In a person who has ingested 180 mg of clonazepam and 30 mg of oxycodone orally, which drug is likely to cause loss of consciousness first?

Which Drug Causes Loss of Consciousness First?

In a massive overdose of 180 mg clonazepam and 30 mg oxycodone, oxycodone will likely cause loss of consciousness first, though both drugs act synergistically to produce profound CNS and respiratory depression that rapidly progresses to life-threatening toxicity.

Mechanism and Timeline

The opioid oxycodone acts primarily at mu receptors to cause CNS depression, respiratory depression, and altered consciousness 1, 2. Benzodiazepines like clonazepam work at GABA-A receptor sites 1. When combined, these drugs have different receptor mechanisms that produce additive or synergistic effects on respiratory and CNS depression 1.

Critical Synergistic Toxicity

The FDA labels explicitly warn that concomitant use of benzodiazepines and opioids increases the risk of respiratory depression, profound sedation, coma, and death 1, 2. This is not simply additive—the interaction can be synergistic:

• Oxycodone causes respiratory depression through mu-receptor agonism
• Clonazepam potentiates this through GABA-A effects
• Clonazepam may also inhibit the metabolism of oxycodone, prolonging and intensifying opioid effects 3

Animal studies confirm that benzodiazepine-opioid combinations produce exacerbated respiratory depression with further decreases in arterial oxygen and increases in carbon dioxide beyond either drug alone 4.

Clinical Presentation in Overdose

At these massive doses (180 mg clonazepam is 90-360 times therapeutic dosing; 30 mg oxycodone is 5-7.5 times a typical single dose):

Immediate effects (minutes to 1-2 hours):

• Severe drowsiness and sedation from both drugs
• Progressive CNS depression leading to loss of consciousness
• Life-threatening respiratory depression
• Risk of aspiration

The fatal case report of combined oxycodone-clonazepam overdose documented pathologies including collapsed lungs, aspirated mucus, heart failure, and severe CNS/respiratory depression 3. The plasma concentrations in that fatality (clonazepam 1.41 mcg/mL, oxycodone 0.60 mcg/mL) were lower than what would be expected from the doses in your question.

Critical Management Pitfalls

Naloxone Limitations

While naloxone reverses opioid-induced respiratory depression 5, it:

• Does NOT reverse benzodiazepine effects
• May produce only transient improvement in mixed overdoses
• Requires repeated dosing or continuous infusion for long-acting opioids like oxycodone 5

One case report documented massive OxyContin ingestion that proved refractory to naloxone therapy, requiring mechanical ventilation for 3 days 6.

Flumazenil Considerations

Flumazenil can reverse benzodiazepine effects but:

• Produces only transient improvement in mixed overdoses 7
• Effects may wear off before the benzodiazepine, requiring repeated dosing
• Risk of precipitating seizures in chronic benzodiazepine users

Immediate Actions Required

This is a medical emergency requiring:

1. Immediate activation of emergency medical services 5
2. Airway management and ventilatory support as primary intervention 5
3. Continuous monitoring for respiratory depression - both drugs can cause prolonged effects
4. Naloxone administration for opioid reversal, but expect need for repeated dosing 5
5. Prolonged observation in healthcare setting - effects can last many hours to days given the massive doses 5, 6

The 2023 AHA guidelines emphasize that patients should be observed in a healthcare setting until risk of recurrent toxicity is low and consciousness/vital signs have normalized 5. With these doses, this will require intensive care unit level monitoring.

The distinction of "which drug causes unconsciousness first" becomes clinically irrelevant—both drugs together create an immediately life-threatening emergency with profound respiratory and CNS depression that can rapidly progress to death without aggressive supportive care.